SCHEMBL8422346

SCHEMBL8422346

Cc1cc2ccccc2n1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.53
▸ LMNA P02545 1/20 0.53
▸ GLA P06280 1/20 0.53
▸ MAPT P10636 1/20 0.53
▸ HTT P42858 1/20 0.53
▸ HSD17B10 Q99714 1/20 0.53
▸ CA1 P00915 18/20 0.53
▸ CA2 P00918 18/20 0.53
▸ CA7 P43166 6/20 0.53
▸ CA13 Q8N1Q1 6/20 0.53
▸ CA12 O43570 3/20 0.53
▸ CA3 P07451 3/20 0.53
▸ CA4 P22748 3/20 0.53
▸ CA6 P23280 3/20 0.53
▸ CA5A P35218 3/20 0.53
▸ CA9 Q16790 3/20 0.53
▸ CA14 Q9ULX7 3/20 0.53
▸ CA5B Q9Y2D0 3/20 0.53
▸ ALDH1A1 P00352 1/20 0.53
▸ GAA P10253 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9630225 0.83 CA1 (0.65) KDM4ELMNAGLAMAPTHTT
SCHEMBL31069942 0.80 KDM4E (0.44) KDM4ELMNAGLAMAPTHTT
SCHEMBL9630166 0.74 CA1 (0.50) KDM4ELMNAGLAMAPTHTT
SCHEMBL11559995 0.74 MAPT (0.53) MAPTCA1CA2CA7CA13
SCHEMBL9630198 0.73 CA1 (0.73) KDM4ELMNAGLAMAPTHTT
SCHEMBL9630937 0.73 CA1 (0.48) KDM4ELMNAGLAMAPTHTT
SCHEMBL13687260 0.72 CA1 (0.66) KDM4ELMNAGLAMAPTHTT
SCHEMBL9630165 0.72 CA1 (0.47) KDM4ELMNAGLAMAPTHTT
SCHEMBL10382771 0.71 CA1 (0.44) KDM4ELMNAGLAMAPTHTT
SCHEMBL9632120 0.71 KDM4E (0.48) KDM4ELMNAGLAMAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110538160-A indapamide tablet and preparation method thereof SUICHENG PHARMACEUTICAL CO LTD 2019-12-06 — — CN disclosed
CN-101717359-A Method for synthesizing indapamide BEIJING CHENGYU PHARMACEUTICAL 2010-06-02 — — CN disclosed
EP-0462016-B1 Process for the industrial preparation of 4-chloro-3-sulfamoyl-N-(2,3-dihydro-2-methyl-1H-indol-1-yl) benzamide ADIR (FR) 1999-09-29 — — EP disclosed
EP-0462017-B1 PROCESS FOR THE INDUSTRIAL PREPARATION OF 3-SULFAMOYL-4-CHLORO-N-(2,3-DIHYDRO-2-METHYL-1H-INDOL-1-YL)BENZAMIDE FROM 2,3-DIHYDRO-2-METHYL-1H-INDOLE AND HYDROXYLAMINE-O-SULFONIC ACID ADIR ET COMPAGNIE (FR) 1993-07-28 — — EP disclosed
US-5110946-A PREPARATION OF 4-CHLORO-3-SULPHAMOYL-N-(2,3-DIHYDRO-2-METHYL-1H-INDOL-1-YL)-BENZAMIDE FROM 2,3-DIHYDRO-2-METHYL-1H-INDOLE AND HYDROXYLAMINE-O-SULPHONIC ACID ADIR ET COMPAGNIE (FR) 1992-05-05 — — US disclosed
US-5101040-A PROCESS FOR THE INDUSTRIAL PREPARATION OF 4-CHLORO-3-SULFAMOYL-N-(2,3-DIHYDRO-2-METHYL-1H-INDOL-1-YL)BENZAMIDE ADIR ET COMPAGNIE (FR) 1992-03-31 — — US disclosed
EP-0462016-A1 Process for the industrial preparation of 4-chloro-3-sulfamoyl-N-(2,3-dihydro-2-methyl-1H-indol-1-yl) benzamide ADIR ET COMPAGNIE (FR) 1991-12-18 — — EP disclosed
EP-0462017-A1 Process for the industrial preparation of 3-sulfamoyl-4-chloro-N-(2,3-dihydro-2-methyl-1H-indol-1-yl)benzamide from 2,3-dihydro-2-methyl-1H-indole and hydroxylamine-O-sulfonic acid ADIR ET COMPAGNIE (FR) 1991-12-18 — — EP disclosed
Send feedback